Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Roche submits European MAA for MabThera

Jan. 21, 2004

Topical imiquimod found safe and effective in squamous cell carcinoma

Jan. 19, 2004

Improved survival found with Provenge(R) in patients with advanced prostate cancer

Jan. 19, 2004

Australian Cancer Technology expands pipeline with European and U.S. focus

Jan. 16, 2004

Chiron expands its phase II program for IL-2 in the treatment of lymphoma

Jan. 15, 2004

Favrille completes enrollment in a phase II clinical trial of FavId for fNHL

Jan. 13, 2004

ImmunoGen to advance TAP compounds into proof-of-concept trials

Jan. 12, 2004

Aphton commences Australian regulatory filing for G17DT

Jan. 8, 2004

Kyowa Hakko presents anti-hIGF antibodies and their therapeutic use

Jan. 8, 2004

DMC recommends continuation of phase III Oncophage trial

Jan. 5, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...